
Home » Oxford Biomedica Signs Five-Year Collaboration for COVID-19 Vaccine Manufacturing
Oxford Biomedica Signs Five-Year Collaboration for COVID-19 Vaccine Manufacturing

Oxford Biomedica has signed a five-year collaboration agreement with the Vaccines Manufacturing and Innovation Center (VMIC) to manufacture viral vector-based vaccines.
The VMIC will provide manufacturing equipment to scale up the manufacturing of AstraZeneca’s COVID-19 vaccine, AZD1222.
The agreement may be expanded for Oxford Biomedica to provide manufacturing capacity for other novel viral-vector vaccine candidates.
Upcoming Events
-
01Feb
-
08Feb
-
09Feb
-
15Feb
-
16Feb
-
22Feb